Leading brokers name 3 ASX shares to sell today

Fortescue Metals Group Limited (ASX:FMG) shares are one of three that leading brokers have named as sells this week…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

On Monday I looked at three ASX shares that have been given buy ratings by leading brokers this week.

Unfortunately, not all shares are in favour with brokers right now. The three shares listed below have all just been given sell ratings. Here's why they are bearish on them:

Fortescue Metals Group Limited (ASX: FMG)

According to a note out of Morgans, its analysts have retained their reduce rating but lifted the price target on this iron ore producer's shares to $6.38 following its full year results. Whilst the result smashed Morgans expectations due to high iron ore prices, the broker is concerned by recent weakness in prices. In light of this and its current valuation, the broker has retained its reduce rating. The Fortescue share price is up 5.5% to $7.56 on Tuesday afternoon.

Goodman Group (ASX: GMG)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating but lifted the price target on this property company's shares to $12.44 following the release of its full year results. According to the note, although Goodman Group delivered a 10.5% increase in earnings per share in FY 2019, Goldman felt the quality of its earnings growth was low in relation to the overall earnings mix. And while the broker thinks Goodman Group is a quality company, it isn't a fan of its current valuation and believes there are better options out there for investors to consider. The Goodman Group share price is down almost 3% to $14.88 today.

Mayne Pharma Group Ltd (ASX: MYX)

Analysts at the Macquarie equites desk have retained their underperform rating and 51 cents price target on this pharmaceutical company's shares. According to the note, the broker appears optimistic that its pipeline of drugs could give its earnings a boost over the medium term, but has concerns over the tough trading conditions it faces in the key generic drugs market at present. In light of this, it intends to stick with its underperform rating until it has seen improvements. Mayne Pharma's shares are down almost 5% to 45.7 cents today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Broker Notes

3 ASX shares upgraded by Morgans to buy ratings

Let's see why the broker has turned positive on these shares.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing start to the trading week.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Wooden blocks spelling rebound with coins on top.
Broker Notes

Can Life360 shares recover from the AI fuelled sell-off?

A leading expert looks into the AI-driven pressure hitting Life360 shares.

Read more »

An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.
Broker Notes

Up 49% in a year, should you buy BHP shares for their 'stability and income'?

A leading expert delivers his forecast for BHP’s fast-rising shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares

Expert analysts reveal their latest recommendations on 3 ASX 200 stocks.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Atlas Arteria, Forrestania, Megaport, and WA1 shares are charging higher today

These shares are starting the week positively. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »